IMCC stock news · IM Cannabis Corp.
Get alerts for IMCC
Follow IM Cannabis Corp. (IMCC) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for IMCCIM Cannabis is allowing current shareholders to sell 2.8 million of their common shares.
NeutralIM Cannabis registered 2.8 million existing shares for holders to resell, but the filing reports no completed sale. The company receives no proceeds, so this does not change its business outlook.
IM Cannabis is set to allow current investors to sell 2.8 million of its common shares.
NeutralIM Cannabis registered 2.8 million existing shares for holders to resell. No sale is reported, and the company gets no proceeds, so this filing does not change its outlook.
Crude oil prices go up by 1%, and Cintas made more money than people thought.
Bad for IMCCIM Cannabis announced a $1.31 million registered direct offering and shares fell 29% to $2.95. The offering and the big share drop signal dilution and investor unease that outweigh the announced 51% acquisition stake.
The Dow dropped 100 points, but General Mills shared good news about its first-quarter profits.
NeutralIM Cannabis announced a $1.31 million share offering and a 51% acquisition while its shares fell 34%; the facts pull in opposite directions.
12 health care companies are changing prices before the market opens on Wednesday.
NeutralIM Cannabis's pre-market pop is reported with no company news, so this report does not change how we read IM Cannabis today.
On Tuesday, 12 health care stocks changed a lot, with Jaguar Health jumping 304.5% and Silexion Therapeutics dropping 3%.
NeutralThe article reports IM Cannabis shares moved up 27.84% intraday. It contains no company announcements, so it does not change how we read IM Cannabis.
On Monday, 12 health care stocks changed a lot in price during trading.
NeutralIM Cannabis fell 23.53% to $3.23, but only the price and market value are reported, so this does not change IM Cannabis' outlook.
On Friday evening, 12 health care stocks saw big changes in their prices.
NeutralIM Cannabis stock fell 11.3% to $3.75 after-market. The article reports only the price move, so it does not change IM Cannabis' prospects.
On Friday, 12 health care stocks changed a lot in price, with IM Cannabis jumping 246%.
NeutralIM Cannabis rose intraday to $6.02, but the article only reports price moves with no company news, so we do not change our view of IM Cannabis.
U.S. stocks had mixed results as industrial production stayed the same in August.
NeutralIM Cannabis shares surged 153% to $4.41, but the article gives no business update, so this price move does not by itself change the company's outlook.
Thursday's intraday session sees significant fluctuations in 12 health care stocks.
Bad for IMCCStock decreased 23.67% in the session, a clear short-term negative.
Restructuring agreement utilized by IM Cannabis to ease financial pressures.
NeutralIM Cannabis Corp. has announced a strategic restructuring deal to divest its subsidiary, which is expected to alleviate financial strain and enhance shareholder equity. This move is crucial for the company's focus on its core operations in the Israeli medical cannabis market, potentially leading to improved financial health and stock performance.